CSIMarket
 
Ernexa Therapeutics Inc   (NASDAQ: ERNA)
 

Ernexa Therapeutics Inc's Suppliers Performance

ERNA's Supply Chain




 
ERNA Costs vs Sales of Suppliers Growth

More on ERNA Suppliers






Ernexa Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers that are inspected by the FDA, DEA, and state agencies to ensure compliance with cGMPs and other regulations. European contractors are subject to regulatory oversight by EU and member state agencies. The company’s control over third-party manufacturers' compliance is limited to contractual obligations. Non-compliance by these contractors may result in product recalls, inventory destruction, production interruptions, and supply delays, negatively impacting the business. Changing manufacturers requires approval from the FDA and foreign regulatory authorities, including testing, inspections, and regulatory submissions, which can lead to delays and increased costs. Additionally, identifying replacement manufacturers is difficult due to a limited number of available options.

Ernexa Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers that are inspected by the FDA, DEA, and state agencies to ensure compliance with cGMPs and other regulations. European contractors are subject to regulatory oversight by EU and member state agencies. The company’s control over third-party manufacturers' compliance is limited to contractual obligations. Non-compliance by these contractors may result in product recalls, inventory destruction, production interruptions, and supply delays, negatively impacting the business. Changing manufacturers requires approval from the FDA and foreign regulatory authorities, including testing, inspections, and regulatory submissions, which can lead to delays and increased costs. Additionally, identifying replacement manufacturers is difficult due to a limited number of available options.







ERNA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Ernexa Therapeutics Inc 4.39 0.58 -12.26 5
SUBTOTAL 0.00 0.00 0.00 -


Sources: Ernexa Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ernexa Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.